title: Acute responses to estradiol replacement in the olfactory system of apoE-deficient and wild-type mice.
abstract: Epidemiological studies suggest that estrogen therapy protects against clinical expression of chronic neurological diseases. These beneficial effects of estrogen therapy are highly modified by apolipoprotein E (apoE) through an unknown mechanism. We examined the short-term effects of estradiol replacement in ovariectomized mice on apoE expression and markers for cell proliferation, reactive gliosis, neuronal maturation, and synaptogenesis in the primary olfactory pathway of wild-type (WT) and apoE knockout (KO) mice. Three days of estradiol replacement increased apoE expression in the olfactory nerve and in the glomerular layer. Estradiol treatment also increased cell proliferation, total cell numbers, number of mature neurons in the olfactory epithelium, and reactive astrocyte numbers in the olfactory bulb (OB) in both WT and KO mice. We also found that estradiol increased glomerular synaptophysin (Syn), but the magnitude of increase was potentiated by the presence of apoE. These data suggest that apoE may be necessary to elicit the complete effect of estradiol on Syn upregulation.
authors.affiliation: Department of Biological Sciences, Eastern Illinois University, 600 Lincoln Avenue, Charleston, IL 61920, USA. bpnathan@eiu.edu
authors.forename: Britto P
authors.initials: BP
authors.lastname: Nathan
authors.forename: Michael
authors.initials: M
authors.lastname: Tonsor
authors.forename: Robert G
authors.initials: RG
authors.lastname: Struble
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics*; D049109:Cell Proliferation / Q000187:drug effects; D004958:Estradiol / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D005911:Gliosis / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D055495:Neurogenesis / Q000187:drug effects / Q000502:physiology; D018696:Neuroprotective Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D009830:Olfactory Bulb / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009832:Olfactory Nerve / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009833:Olfactory Pathways / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010052:Ovariectomy; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
chemical_list: D001057:Apolipoproteins E; D018696:Neuroprotective Agents; D004958:Estradiol
references.citation: J Neuroimmunol. 2008 Mar;195(1-2):47-59
references.pmid: 18328572
references.citation: J Neuroendocrinol. 2009 Mar;21(3):155-66
references.pmid: 19076272
references.citation: Brain Res. 2005 Apr 11;1041(1):87-94
references.pmid: 15804503
references.citation: J Am Geriatr Soc. 1998 Dec;46(12):1493-8
references.pmid: 9848808
references.citation: Arch Biochem Biophys. 1986 Sep;249(2):351-62
references.pmid: 3753006
references.citation: Exp Cell Res. 2005 Jun 10;306(2):309-16
references.pmid: 15925585
references.citation: JAMA. 2003 May 28;289(20):2651-62
references.pmid: 12771112
references.citation: J Comp Neurol. 2003 May 19;460(1):123-40
references.pmid: 12687701
references.citation: Neuroscience. 2006;138(3):1031-9
references.pmid: 16310963
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16983-8
references.pmid: 17077142
references.citation: Biochem Mol Biol Int. 1996 Feb;38(1):91-101
references.pmid: 8932523
references.citation: Brain Res. 2008 Apr 8;1203:177-88
references.pmid: 18316064
references.citation: Neurosci Lett. 2007 Apr 24;417(1):50-4
references.pmid: 17346883
references.citation: Neuroscience. 1999;91(3):1009-16
references.pmid: 10391478
references.citation: Neurosci Lett. 2008 Aug 29;441(3):282-5
references.pmid: 18621483
references.citation: Ann N Y Acad Sci. 1998 Nov 30;855:744-50
references.pmid: 9929680
references.citation: Biochim Biophys Acta. 1987 Jan 13;917(1):148-61
references.pmid: 3539206
references.citation: J Alzheimers Dis. 2004 Jun;6(3):221-8
references.pmid: 15201477
references.citation: Exp Neurol. 2003 Oct;183(2):638-44
references.pmid: 14552905
references.citation: Brain Res. 2007 Mar 16;1137(1):78-83
references.pmid: 17239830
references.citation: Neurosci Lett. 1999 May 28;267(2):137-40
references.pmid: 10400231
references.citation: Brain Res. 1999 Apr 10;824(2):312-5
references.pmid: 10196466
references.citation: Lancet. 1996 Aug 17;348(9025):429-32
references.pmid: 8709781
references.citation: Front Neuroendocrinol. 2009 Aug;30(3):343-57
references.pmid: 19361542
references.citation: Can J Physiol Pharmacol. 1987 Apr;65(4):563-7
references.pmid: 3607603
references.citation: Ann N Y Acad Sci. 1998 Nov 30;855:723-31
references.pmid: 9929677
references.citation: Stroke. 1985 Nov-Dec;16(6):980-4
references.pmid: 3937302
references.citation: J Biol Chem. 1997 Dec 26;272(52):33360-6
references.pmid: 9407129
references.citation: J Neurosci. 1998 May 1;18(9):3180-5
references.pmid: 9547226
references.citation: J Cereb Blood Flow Metab. 2002 Oct;22(10):1189-95
references.pmid: 12368657
references.citation: Brain Res Dev Brain Res. 1989 Jun 1;47(2):298-302
references.pmid: 2743562
references.citation: J Neurosci. 2004 Jun 23;24(25):5670-83
references.pmid: 15215289
references.citation: Neurology. 2000 May 23;54(10):1949-54
references.pmid: 10822435
references.citation: Neuroscience. 1980;5(7):1239-52
references.pmid: 7402467
references.citation: Am J Epidemiol. 1994 Aug 1;140(3):256-61
references.pmid: 8030628
references.citation: Adv Protein Chem. 1994;45:249-302
references.pmid: 8154371
references.citation: Exp Gerontol. 2007 Jan-Feb;42(1-2):54-63
references.pmid: 16837159
references.citation: Exp Neurol. 1995 Dec;136(2):107-22
references.pmid: 7498401
references.citation: Exp Neurol. 1997 Feb;143(2):313-8
references.pmid: 9056393
references.citation: Mol Cell Biochem. 2001 Apr;220(1-2):87-93
references.pmid: 11451387
references.citation: J Clin Exp Neuropsychol. 2004 Sep;26(6):779-94
references.pmid: 15370375
references.citation: Exp Neurol. 2001 Nov;172(1):128-36
references.pmid: 11681846
references.citation: JAMA. 2004 Jun 23;291(24):2959-68
references.pmid: 15213207
references.citation: J Comp Neurol. 1995 Dec 4;363(1):129-46
references.pmid: 8682932
references.citation: Exp Neurol. 2006 Jan;197(1):197-205
references.pmid: 16226751
references.citation: J Neurocytol. 1979 Apr;8(2):197-213
references.pmid: 469573
references.citation: Neuroendocrinology. 2006;83(5-6):325-35
references.pmid: 16926532
references.citation: Endocrinology. 2004 Jul;145(7):3065-73
references.pmid: 15033916
references.citation: Brain Cogn. 2005 Jul;58(2):178-82
references.pmid: 15919549